Thrombopoietin receptor agonists in hereditary thrombocytopenias
- 28 June 2018
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 16 (9) , 1700-1710
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Telethon (GGP17106)
- Fondazione IRCCS Policlinico San Matteo
- Novartis Pharmaceuticals Corporation
This publication has 72 references indexed in Scilit:
- First Successful Use of Eltrombopag Before Surgery in a Child With MYH9-Related ThrombocytopeniaPediatrics, 2013
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopeniaBlood, 2013
- Iron Chelation in the Treatment of Cancer: A New Role for Deferasirox?The Journal of Clinical Pharmacology, 2013
- Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyBlood, 2013
- Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb (Bolzano mutation)Haematologica, 2011
- Recent advances in the understanding and management of MYH9‐related inherited thrombocytopeniasBritish Journal of Haematology, 2011
- Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3pBlood, 2010
- F104S c-Mpl responds to a transmembrane domain−binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agentsExperimental Hematology, 2010
- MYH-9 Related Platelet Disorders: Strategies for Management and DiagnosisTransfusion Medicine and Hemotherapy, 2010
- Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromeBlood, 2009